Product ID:PRESTONE ANTIFREEZE/COOLANT
MSDS Date:09/25/1995
FSC:6850
NIIN:01-252-8501
MSDS Number: CJSQZ

PRESTONE PRODUCTS CORP

39 OLD RIDGEBURRY RD
DANBURY, CT 06513-5109
US

Emergency Phone: 203-830-7800

Info Phone: 203-731-7800

Preparer: JAMES L OTTOWITZ

Cage: 0CXZ7

PRESTONE PRODUCTS CORPORATION

DANBURY, CT 06810 US

Telephone: 203-830-7865

Cage: EO340

ETHYLENE GLYCOL (SARA III)

CAS: 107-21-1

RTECS: KW2975000

OSHA PEL C 50 PPM

ACGIH TLV: C 50 PPM,VAPOR; 9192

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

DIETHYLENE GLYCOL

CAS: 111-46-6

RTECS: ID5950000

WATER

CAS: 7732-18-5

RTECS: ZC0110000

Routes of Entry: Inhalation:YES Skin:UNKNOWN Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:SWALLOWING-MAY CAUSE ABDOMINAL
DISCOMFORT, PAIN, NAUSEA, VOMITING, DIZZINESS, MALAISE, BLURRING OF
VISION, IRRITABILITY, FLANK PAIN, DECREASE URINE PRODUCTION &
CENTRAL NERVOUS SYSTEM EFFECTS INCLUDIN G IRREGULAR EYE MOVEMENT,
CONVULSIONS &COMA. CARDIAC FAILURE & PULMONARY EDEMA MAY DEVELOP.
SEVERE KIDNEY DAMAGE FOLLOWS SWALLOWING LARGE VOLUMES. MAY BE
FATAL. INHALATION-MAY CAUSE IRRITATION OF NOSE & THROAT WITH
HEADACHE, PARTICULARLY FROM MISTS. SKIN-NO EVIDENCE OF ADVERSE
EFFECTS FROM AVAILABLE INFO. EYE-LIQUID, VAPOR & MIST MAY CAUSE
DISCOMFORT IN THE EYE WITH PERSISTENT CONJUNCTIVITIS, SEEN AS
EXCESS REDNESS OF THE CONJUNCTIVA.
Effects of Overexposure:INGESTION WITH A BITTER TASTE, ABDOMINAL
DISCOMFORT, PAIN, NAUSEA, VOMITING, DIZZINESS, MALAISE, BLURRING OF
VISION, IRRITABILITY, FLANK PAIN, DECREASE URINE PRODUCTION, AND
CNS EFFECTS, IRREGULAR EYE MOVEMENTS, CONVULSIONS, COMA. CARDIAC
FAILURE, PULMONARY EDEMA, SEVERE KIDNEY DAMAGE, REDNESS OF THE
CONJUNCTIVA, NYSTAGMUS. SKIN SENSITIZATION AND AN ASSOCIATED
DERMITITIS.
Medical Cond Aggravated by Exposure:MAY AGGRAVATE EXISTING KIDNEY
DISEASE.

First Aid:SWALLOWING-GET MEDICAL AID BY IMMEDIATELY CALLING A
PHYSICIAN, EMERGENCY ROOM OR POISON CONTROL CENTER. IF VICTIM IS
CONSCIOUS & ALERT IMMEDIATELY INDUCE VOMITING. TAKE THE VICTIM &
CONTAINER TO THE N EAREST EMERGENCY ROOM FOR DEFINITIVE TREATMENT.
SKIN-REMOVE CONTAMINATED CLOTHING & SHOES. IMMEDIATELY WASH WITH
SOAP & WATER, OR REDNESS DEVELOPS & PERSISTS, SEEK MEDICAL AID.
INHALATION-REMOVE TO FR ESH AIR. IF BREATHING BECOMES DIFFICULT,
ADMINISTER OXYGEN. ADMINISTER ARTIFICIAL RESPIRATION IF BREATHING
HAS STOPPED, & SEEK IMMEDIATE MEDICAL AID. EYES-IMMEDIATELY FLUSH
EYES WITH COPIOUS AMOUNTS O F WATER. SEEK IMMEDIATE MEDICAL AID.

Flash Point Method:TOC
Flash Point:=116.7C, 242.F
Lower Limits:3.2, CALC.
Upper Limits:15.3, EST.
Extinguishing Media:APPLY ALCOHOL TYPE OR ALL-PURPOSE TYPE FOAMS BY
MANUFACTURERS RECOMMENDED TECHNIQUES FOR LARGE FIRES. USE WATER
SPRAY, CARBON DIOXIDE OR DRY CHEMICAL MEDIA FOR SMALL FIRES.
Fire Fighting Procedures:DON'T SPRAY POOL FIRES DIRECTLY.A SOLID STREAM
OF WATER OR FOAM DIRECTED INTO HOT, BURNING LIQUID CAN CAUSE
FROTHING. USE SELF-CONTAINED BREATHING APPARATUS AND PROTECTIVE
CLOTHING.
Unusual Fire/Explosion Hazard:NONE.

Spill Release Procedures:WEAR SUITABLE PROTECTIVE EQUIPMENT. SMALL
SPILLS SHOULD BE FLUSHED WITH LARGE QUANTITIES OF WATER. LARGER
SPILLS SHOULD BE COLLECTED FOR DISPOSAL.

Handling and Storage Precautions:DON'T DRINK ANTIFREEZE OR SOLUTION.
AVOID BREATHING VAPOR OR MISTS. DON'T STORE IN OPENED OR UNLABELED
CONTAINERS. WASH EXPOSED SKIN THOROUGHLY WITH SOAP AND WATER AFTER
USE.
Other Precautions:KEEP AWAY FROM OPEN FLAMES AND EXCESSIVE HEAT. DON'T
REUSE EMPTY CONTAINERS UNLESS PROPERLY CLEANED. KEEP OUT OF REACH
OF CHILDREN. DO NOT CUT OR WELD NEAR CONTAINER, EVEN EMPTY. OBSERVE
ALL REQUIREME NTS OF PLANT, COMPANY OR GOVERNMENT REGULATIONS.

Respiratory Protection:WHERE THE TLV MAY BE EXCEEDED, A NIOSH/MSHA
APPROVED RESPIRATOR WITH AN ORGANIC VAPOR CARTRIDGE AND A DUST/MIST
PRE-FILTER OR A SUPPLIED AIR RESPIRATOR IS RECOMMENDED. EQUIPMENT
SELECTION DEPENDS ON C ONTAMINANT TYPE AND CONCENTRATION, SELECT IN
ACCORDANCE WITH 29CFR 1910.134 AND GOOD INDUSTRIAL HYGIENE
PRACTICE. FOR FIREFIGHTING, USE SCBA.
Ventilation:GENERAL VENTILATION SHOULD BE ADEQUATE FOR NORMAL USE. IF
HEATED OR MISTED AND TLV EXCEEDED, FORCED VENTILATION SUCH AS LOCAL
EXHAUST MAY BE NEEDED.
Protective Gloves:CHEMICAL RESISTANT, SUCH AS NEOPRENE/PVC COATED,
GLOVES RECOMMENDED
Eye Protection:SPLASH-PROOF GOGGLES RECOMMENDED.
Other Protective Equipment:PROTECTIVE CLOTHING IF NEEDED TO AVOID
PROLONGED/REPEATED SKIN CONTACT. SUITABLE WASHING AND EYE FLUSHING
FACILITIES SHOULD BE AVAILABLE IN THE WORK AREA.
Work Hygienic Practices:WASH EXPOSED SKIN THOROUGHLY WITH SOAP & WATER
AFTER USE. CONTAMINATED CLOTHING SHOULD BE REMOVED AND LAUNDERED
BEFORE RE-USE.
Supplemental Safety and Health
NOTE TO PHYSICIAN: THE PRINCIPLE EFFECTS OF ETHYLENE GLYCOL, WHEN
SWALLOWED, ARE KIDNEY DAMAGE & METABOLIC ACIDOSIS. ETHANOL IS
ANTIDOTAL & ITS EARLY ADMINISTRATION MAY BLOCK THE FORMATION OF
NEPHROTO XIC METABOLITES OF ETHYLENE GLYCOL IN THE LIVER.

HCC:V5
Boiling Pt:=167.8C, 334.F
Melt/Freeze Pt:=-22.2C, -8.F
Vapor Pres:<0.1 @68F
Vapor Density:2.1(AIR=1)
Spec Gravity:9.4 LBS/GAL(68F)
pH:NONE .
Evaporation Rate & Reference:<1 (BU ACETATE=1)
Solubility in Water:100%
Appearance and Odor:YELLOW, MILD ODOR.
Percent Volatiles by Volume:NONE

Stability Indicator/Materials to Avoid:YES
NORMALLY NON-REACTIVE. HOWEVER, AVOID STRONG BASES AT HIGH
TEMPERATURES, STRONG ACIDS, STRONG OXIDIZING AGENTS AND MATERIALS
REACTIVE WITH HYDROXYL COMPOUNDS.
Stability Condition to Avoid:NONE.
Hazardous Decomposition Products:BURNING MAY PRODUCE CARBON DIOXIDE
AND/OR CARBON MONOXIDE.

Waste Disposal Methods:INCINERATE IN A FURNACE WHERE PERMITTED UNDER
APPROPRIATE FEDERAL, STATE OR LOCAL REGULATIONS. AT VERY LOW
CONCENTRATION IN WATER, ETHYLENE GLYCOL IS READILY BIODEGRADABLE IN
A BIOLOGICAL WASTEWATER T REATMENT PLANT.

Toxicological Information:ETHYLENE GLYCOL HAS BEEN SHOWN TO PRODUCE
DOSE-RELATED TERATOGENIC EFFECTS IN RATS & MICE WHEN GIVEN BY
GAVAGE OR IN DRINKING WATER AT HIGH CONCENTRATIONS OR DOSES. ALSO,
IN A PRELIMINARY STUDY TO ASS ESS THE EFFECTS OF EXPOSURE OF
PREGNANT RATS TO AEROSOLS AT CONCENTRATIONS 150, 1000 & 2500 MG/M3
FOR 6 HRS A DAY THROUGHOUT THE PERIOD OF ORGANOGENESIS, TERATOGENIC
EFFECTS WERE PRODUCED AT THE HIGH EST CONCENTRATIONS, BUT ONLY IN
MICE.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Ecological:NOT PROVIDED

Transport Information:HAZARD CLASSIFICATION: NONE.

SARA Title III Information:THIS PRODUCT CONTAINS THE FOLLOWING
CHEMICALS SUBJECT TO THE SARA TITLE III, SECTION 313 REPORTING:
ETHYLENE GLYCOL, CAS# 107-21-1, 85-95%.
Federal Regulatory Information:NOT PROVIDED
State Regulatory Information:CALIFORNIA PROPOSITION 65: THIS PRODUCT
CONTAINS TRACE LEVELS OF CHEMICALS WHICH THE STATE OF CALIFORNIA
HAS FOUND TO CAUSE CANCER AND/OR BIRTH DEFECTS OR OTHER
REPRODUCTIVE HARM.